{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:03:56Z","timestamp":1793916236661,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-03883-x","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:30:07Z","timestamp":1730190607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and safety of botulinum neurotoxin in the treatment of hemifacial spasms: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Bingqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XingFu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"9","key":"3883_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/mds.23692","volume":"26","author":"TC Yaltho","year":"2011","unstructured":"Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011;26(9):1582\u201392. https:\/\/doi.org\/10.1002\/mds.23692.","journal-title":"Mov Disord"},{"issue":"3","key":"3883_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1468-1331.2006.01670.x","volume":"14","author":"K Heuser","year":"2007","unstructured":"Heuser K, Kerty E, Eide PK, Cvancarova M, Dietrichs E. Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality. Eur J Neurol. 2007;14(3):335\u201340. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01670.x.","journal-title":"Eur J Neurol"},{"issue":"8","key":"3883_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00701-014-2132-7","volume":"156","author":"F Perren","year":"2014","unstructured":"Perren F, Magistris MR. Is hemifacial spasm accompanied by hemodynamic changes detectable by ultrasound? Article. Acta Neurochirurgica. 2014;156(8):1557\u201360. https:\/\/doi.org\/10.1007\/s00701-014-2132-7.","journal-title":"Acta Neurochirurgica"},{"issue":"2014","key":"3883_CR4","doi-asserted-by":"publisher","first-page":"349319","DOI":"10.1155\/2014\/349319","volume":"2014","author":"AY Lu","year":"2014","unstructured":"Lu AY, Yeung JT, Gerrard JL, Michaelides EM, Sekula RF, Bulsara KR. Hemifacial spasm and neurovascular compression. TheScientificWorldJOURNAL. 2014;2014(2014):349319. https:\/\/doi.org\/10.1155\/2014\/349319.","journal-title":"TheScientificWorldJOURNAL"},{"issue":"2","key":"3883_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/ijo.IJO_415_20","volume":"69","author":"P Banerjee","year":"2021","unstructured":"Banerjee P, Alam MS, Koka K, Pherwani R, Noronha OV, Mukherjee B. Role of neuroimaging in cases of primary and secondary hemifacial spasm. Indian J Ophthalmol. 2021;69(2):253\u20136. https:\/\/doi.org\/10.4103\/ijo.IJO_415_20.","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"3883_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/mds.25472","volume":"28","author":"M Pawlowski","year":"2013","unstructured":"Pawlowski M, Gess B, Evers S. The Babinski-2 sign in hemifacial spasm. Mov Disord. 2013;28(9):1298\u2013300. https:\/\/doi.org\/10.1002\/mds.25472.","journal-title":"Mov Disord"},{"issue":"2","key":"3883_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuchi.2017.12.003","volume":"64","author":"JP Lefaucheur","year":"2018","unstructured":"Lefaucheur JP, Ben Daamer N, Sangla S, Le Guerinel C. Diagnosis of primary hemifacial spasm. Neurochirurgie. 2018;64(2):82\u20136. https:\/\/doi.org\/10.1016\/j.neuchi.2017.12.003.","journal-title":"Neurochirurgie"},{"issue":"2","key":"3883_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuchi.2018.01.005","volume":"64","author":"M Hermier","year":"2018","unstructured":"Hermier M. Imaging of hemifacial spasm. Neurochirurgie. 2018;64(2):117\u201323. https:\/\/doi.org\/10.1016\/j.neuchi.2018.01.005.","journal-title":"Neurochirurgie"},{"issue":"1","key":"3883_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/iio.0000000000000203","volume":"58","author":"DJ Ozzello","year":"2018","unstructured":"Ozzello DJ, Giacometti JN. Botulinum toxins for treating essential blepharospasm and hemifacial spasm. Int Ophthalmol Clin Winter. 2018;58(1):49\u201361. https:\/\/doi.org\/10.1097\/iio.0000000000000203.","journal-title":"Int Ophthalmol Clin Winter"},{"key":"3883_CR10","doi-asserted-by":"publisher","first-page":"106555","DOI":"10.1016\/j.clineuro.2021.106555","volume":"203","author":"Y Herrero-Infante","year":"2021","unstructured":"Herrero-Infante Y, Rodr\u00edguez-Sanz A, M\u00e1\u00f1ez-Mir\u00f3 J, Vivancos-Matellano F. Hemifacial spasm through the last three decades: from etiology to efficacy and safety of long-term botulinum toxin treatment. Clin Neurol Neurosurg. 2021;203:106555. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106555.","journal-title":"Clin Neurol Neurosurg"},{"issue":"SUPPL. 1","key":"3883_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01442.x","volume":"13","author":"K Frei","year":"2006","unstructured":"Frei K, Truong DD, Dressler D. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Conference Paper. Eur J Neurol. 2006;13(SUPPL. 1):30\u20135. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01442.x.","journal-title":"Eur J Neurol"},{"key":"3883_CR12","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/j.wneu.2021.03.133","volume":"151","author":"S Lee","year":"2021","unstructured":"Lee S, Joo KM, Park K. Challenging microvascular decompression surgery for hemifacial spasm. World Neurosurg. 2021;151:e94\u20139. https:\/\/doi.org\/10.1016\/j.wneu.2021.03.133.","journal-title":"World Neurosurg"},{"issue":"3","key":"3883_CR13","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s10143-022-01739-x","volume":"45","author":"J Li","year":"2022","unstructured":"Li J, Lyu L, Chen C, Yin S, Jiang S, Zhou P. The outcome of microvascular decompression for hemifacial spasm: a systematic review and meta-analysis. Neurosurg Rev. 2022;45(3):2201\u201310. https:\/\/doi.org\/10.1007\/s10143-022-01739-x.","journal-title":"Neurosurg Rev"},{"issue":"2","key":"3883_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/2042533312472115","volume":"4","author":"R Persaud","year":"2013","unstructured":"Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K. An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep. 2013;4(2):10. https:\/\/doi.org\/10.1177\/2042533312472115.","journal-title":"JRSM Short Rep"},{"issue":"1\u20132","key":"3883_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2015.06.032","volume":"356","author":"N Chaudhry","year":"2015","unstructured":"Chaudhry N, Srivastava A, Joshi L. Hemifacial spasm: the past, present and future. J Neurol Sci. 2015;356(1\u20132):27\u201331. https:\/\/doi.org\/10.1016\/j.jns.2015.06.032.","journal-title":"J Neurol Sci"},{"key":"3883_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178\u201389. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.03.001.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"3883_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00702-010-0416-5","volume":"117","author":"M Rudzi\u0144ska","year":"2010","unstructured":"Rudzi\u0144ska M, W\u00f3jcik M, Szczudlik A. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy. J Neural Transm (Vienna). 2010;117(6):765\u201372. https:\/\/doi.org\/10.1007\/s00702-010-0416-5.","journal-title":"J Neural Transm (Vienna)"},{"issue":"43","key":"3883_CR18","doi-asserted-by":"publisher","first-page":"e12819","DOI":"10.1097\/md.0000000000012819","volume":"97","author":"X Li","year":"2018","unstructured":"Li X, Zhang L, Gu S, et al. Comparative effectiveness of extracorporeal shock wave, ultrasound, low-level laser therapy, noninvasive interactive neurostimulation, and pulsed radiofrequency treatment for treating plantar fasciitis: a systematic review and network meta-analysis. Medicine (Baltimore). 2018;97(43):e12819. https:\/\/doi.org\/10.1097\/md.0000000000012819.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"3883_CR19","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.3390\/ijerph19084599","volume":"19","author":"GF Papalia","year":"2022","unstructured":"Papalia GF, Petrucci G, Russo F, et al. COVID-19 pandemic increases the impact of low back pain: a systematic review and metanalysis. Int J Environ Res Public Health. 2022;19(8):4599. https:\/\/doi.org\/10.3390\/ijerph19084599.","journal-title":"Int J Environ Res Public Health"},{"issue":"7414","key":"3883_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"7","key":"3883_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10654-020-00650-3","volume":"35","author":"MCS Wong","year":"2020","unstructured":"Wong MCS, Huang J, Wang J, et al. Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673\u201383. https:\/\/doi.org\/10.1007\/s10654-020-00650-3.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"3883_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/2049-3258-72-39","volume":"72","author":"VN Nyaga","year":"2014","unstructured":"Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39. https:\/\/doi.org\/10.1186\/2049-3258-72-39.","journal-title":"Arch Public Health"},{"issue":"5","key":"3883_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000327534","volume":"65","author":"BD Colakoglu","year":"2011","unstructured":"Colakoglu BD, Cakmur R, Uzunel F. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial. Eur Neurol. 2011;65(5):286\u201390. https:\/\/doi.org\/10.1159\/000327534.","journal-title":"Eur Neurol"},{"issue":"5","key":"3883_CR24","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s12325-022-02077-6","volume":"39","author":"S Jitpimolmard","year":"2022","unstructured":"Jitpimolmard S, Thinkhamrop B, Tiamkao S, et al. A double-blind, placebo-controlled study of appropriate site of botulinum toxin therapy in hemifacial spasm. Adv Ther. 2022;39(5):2025\u201334. https:\/\/doi.org\/10.1007\/s12325-022-02077-6.","journal-title":"Adv Ther"},{"issue":"1","key":"3883_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000008121","volume":"43","author":"JD Rollnik","year":"2000","unstructured":"Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Eur Neurol. 2000;43(1):9\u201312. https:\/\/doi.org\/10.1159\/000008121.","journal-title":"Eur Neurol"},{"issue":"3","key":"3883_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archneur.59.3.418","volume":"59","author":"G Defazio","year":"2002","unstructured":"Defazio G, Abbruzzese G, Girlanda P, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol. 2002;59(3):418\u201320. https:\/\/doi.org\/10.1001\/archneur.59.3.418.","journal-title":"Arch Neurol"},{"issue":"6","key":"3883_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord. 2002;17(6):1288\u201393. https:\/\/doi.org\/10.1002\/mds.10252.","journal-title":"Mov Disord"},{"key":"3883_CR28","first-page":"447","volume":"51","author":"M Gupta","year":"2003","unstructured":"Gupta M, Singh G, Khwaja G. Botulinum toxin in the treatment of dystonias\u2013a hospital based study. J Assoc Physicians India. 2003;51:447\u201353.","journal-title":"J Assoc Physicians India"},{"issue":"3","key":"3883_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.47102\/annals-acadmedsg.V33N3p324","volume":"33","author":"WL Au","year":"2004","unstructured":"Au WL, Tan LC, Tan AK. Hemifacial spasm in Singapore: clinical characteristics and patients\u2019 perceptions. Ann Acad Med Singap. 2004;33(3):324\u20138.","journal-title":"Ann Acad Med Singap"},{"issue":"4","key":"3883_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10384-005-0200-5","volume":"49","author":"A Poonyathalang","year":"2005","unstructured":"Poonyathalang A, Preechawat P, Jamnansiri U. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm. Jpn J Ophthalmol Jul-Aug. 2005;49(4):327\u20138. https:\/\/doi.org\/10.1007\/s10384-005-0200-5.","journal-title":"Jpn J Ophthalmol Jul-Aug"},{"issue":"8","key":"3883_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.eye.6702054","volume":"20","author":"E Ortisi","year":"2006","unstructured":"Ortisi E, Henderson HW, Bunce C, Xing W, Collin JR. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases. Eye (Lond). 2006;20(8):916\u201322. https:\/\/doi.org\/10.1038\/sj.eye.6702054.","journal-title":"Eye (Lond)"},{"issue":"4","key":"3883_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00702-009-0200-6","volume":"116","author":"B Mohammadi","year":"2009","unstructured":"Mohammadi B, Kollewe K, Wegener M, Bigalke H, Dengler R. Experience with long-term treatment with albumin-supplemented botulinum toxin type A. J Neural Transm (Vienna). 2009;116(4):437\u201341. https:\/\/doi.org\/10.1007\/s00702-009-0200-6.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"3883_CR33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1590\/s0004-282x2010000400006","volume":"68","author":"ER Barbosa","year":"2010","unstructured":"Barbosa ER, Takada LT, Gon\u00e7alves LR, Costa RM, Silveira-Moriyama L, Chien HF. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience. Arq Neuropsiquiatr. 2010;68(4):502\u20135. https:\/\/doi.org\/10.1590\/s0004-282x2010000400006.","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"3883_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00702-010-0409-4","volume":"117","author":"K Kollewe","year":"2010","unstructured":"Kollewe K, Mohammadi B, Dengler R, Dressler D. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. J Neural Transm (Vienna). 2010;117(6):759\u201363. https:\/\/doi.org\/10.1007\/s00702-010-0409-4.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"3883_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4274\/Tnd.26097","volume":"18","author":"A \u00c7oban","year":"2012","unstructured":"\u00c7oban A, Matur Z, Hana\u01e7asi HA, Parman Y. Efficacy of botulinum toxin injections in the treatment of various types of facial region disorders. Article Turk Noroloji Dergisi. 2012;18(4):133\u201361. https:\/\/doi.org\/10.4274\/Tnd.26097.","journal-title":"Article Turk Noroloji Dergisi"},{"issue":"5","key":"3883_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3760\/cma.j.issn.0366-6999.20132912","volume":"127","author":"L Wang","year":"2014","unstructured":"Wang L, Hu X, Dong H, et al. Clinical features and treatment status of hemifacial spasm in China. Chin Med J (Engl). 2014;127(5):845\u20139.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"3883_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OH Ababneh","year":"2014","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol. 2014;42(3):254\u201361. https:\/\/doi.org\/10.1111\/ceo.12165.","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"3883_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jocn.2015.02.032","volume":"22","author":"MH Sorgun","year":"2015","unstructured":"Sorgun MH, Yilmaz R, Akin YA, Mercan FN, Akbostanci MC. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015;22(8):1319\u201325. https:\/\/doi.org\/10.1016\/j.jocn.2015.02.032.","journal-title":"J Clin Neurosci"},{"issue":"9","key":"3883_CR39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3109\/00016489.2016.1165864","volume":"136","author":"WJ Choe","year":"2016","unstructured":"Choe WJ, Kim J. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm. Acta Otolaryngol. 2016;136(9):952\u20135. https:\/\/doi.org\/10.3109\/00016489.2016.1165864.","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"3883_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4274\/tnd.04809","volume":"22","author":"HR Koyuncuo\u011flu","year":"2016","unstructured":"Koyuncuo\u011flu HR, Demirci S. Applications of botulinum toxin at a neurology clinic: an eleven-year experience. Article. Turk Noroloji Dergisi. 2016;22(1):8\u201312. https:\/\/doi.org\/10.4274\/tnd.04809.","journal-title":"Turk Noroloji Dergisi"},{"issue":"2","key":"3883_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/0004-282x20160191","volume":"75","author":"JP Batisti","year":"2017","unstructured":"Batisti JP, Kleinfelder AD, Galli NB, Moro A, Munhoz RP, Teive HA. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated. Arq Neuropsiquiatr. 2017;75(2):87\u201391. https:\/\/doi.org\/10.1590\/0004-282x20160191.","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"3883_CR42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4103\/0028-3886.236959","volume":"66","author":"S Pandey","year":"2018","unstructured":"Pandey S, Jain S. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm. Neurol India. 2018;66(4):1036\u201342. https:\/\/doi.org\/10.4103\/0028-3886.236959.","journal-title":"Neurol India"},{"key":"3883_CR43","doi-asserted-by":"publisher","first-page":"106632","DOI":"10.1016\/j.clineuro.2021.106632","volume":"205","author":"SAS Gutierrez","year":"2021","unstructured":"Gutierrez SAS, Yu JRT, Yalung PM, Jamora RDG. Real-world experience with botulinum toxin A for the treatment of hemifacial spasm: a study of 1138 injections. Clin Neurol Neurosurg. 2021;205:106632. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106632.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"3883_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/toxins14050362","volume":"14","author":"G Yahalom","year":"2022","unstructured":"Yahalom G, Janah A, Rajz G, Eichel R. Therapeutic approach to botulinum injections for hemifacial spasm, synkinesis and blepharospasm. Toxins (Basel). 2022;14(5):362. https:\/\/doi.org\/10.3390\/toxins14050362.","journal-title":"Toxins (Basel)"},{"issue":"2","key":"3883_CR45","doi-asserted-by":"publisher","first-page":"e24898","DOI":"10.1016\/j.heliyon.2024.e24898","volume":"10","author":"S Tian","year":"2024","unstructured":"Tian S, Zheng H, Wu L, Wu W. Factors influencing short-term prognosis after botulinum toxin type A treatment for hemifacial spasm: a retrospective study. Heliyon. 2024;10(2):e24898. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24898.","journal-title":"Heliyon"},{"issue":"10","key":"3883_CR46","first-page":"1205","volume":"87","author":"A Suputtitada","year":"2004","unstructured":"Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC. Hemifacial spasm: results of treatment with low dose botulinum toxin injection. J Med Assoc Thai. 2004;87(10):1205\u201311.","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"3883_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jocn.2007.02.002","volume":"15","author":"T Tun\u00e7","year":"2008","unstructured":"Tun\u00e7 T, Cavdar L, Karada\u011f YS, Okuyucu E, Co\u015fkun O, Inan LE. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment. J Clin Neurosci. 2008;15(3):253\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2007.02.002.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"3883_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/eye.2009.192","volume":"24","author":"S Cillino","year":"2010","unstructured":"Cillino S, Raimondi G, Gu\u00e9pratte N, et al. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye (Lond). 2010;24(4):600\u20137. https:\/\/doi.org\/10.1038\/eye.2009.192.","journal-title":"Eye (Lond)"},{"issue":"2","key":"3883_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5114\/ninp.2012.28254","volume":"46","author":"M Rudzi\u0144ska","year":"2012","unstructured":"Rudzi\u0144ska M, W\u00f3jcik M, Malec M, et al. Factors affecting the quality of life in hemifacial spasm patients. Article. Neurologia i Neurochirurgia Polska. 2012;46(2):121\u20139. https:\/\/doi.org\/10.5114\/ninp.2012.28254.","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"1","key":"3883_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.npbr.2012.08.001","volume":"19","author":"AE G\u00fcrsoy","year":"2013","unstructured":"G\u00fcrsoy AE, Ugurad I, Babacan-Yildiz G, Kolukisa M, \u00c7elebi A. Effects of botulinum toxin type A on quality of life assessed with the WHOQOL-BREF in hemifacial spasm and blepharospasm. Article. Neurol Psychiatry Brain Res. 2013;19(1):12\u20138.","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"4","key":"3883_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1756285616682676","volume":"10","author":"D Weiss","year":"2017","unstructured":"Weiss D, Sturm J, Hieber L, et al. Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm. Ther Adv Neurol Disord. 2017;10(4):211\u20136. https:\/\/doi.org\/10.1177\/1756285616682676.","journal-title":"Ther Adv Neurol Disord"},{"key":"3883_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/ndt.S181820","volume":"15","author":"H Dong","year":"2019","unstructured":"Dong H, Fan S, Luo Y, Peng B. Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. Neuropsychiatr Dis Treat. 2019;15:33\u20136. https:\/\/doi.org\/10.2147\/ndt.S181820.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"3883_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13760-018-1018-5","volume":"119","author":"B Yuksel","year":"2019","unstructured":"Yuksel B, Genc F, Yaman A, Goksu EO, Ak PD, Gomceli YB. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment. Acta Neurol Belg. 2019;119(1):55\u201360. https:\/\/doi.org\/10.1007\/s13760-018-1018-5.","journal-title":"Acta Neurol Belg"},{"key":"3883_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2021.11.006","author":"JS Wei","year":"2022","unstructured":"Wei JS, Hu X, Xia L, Shang J, Han Q, Zhang DY. Evaluation of the effect of botulinum toxin A on the physical and mental health of patients with hemifacial spasm. Article in Press. Neurologia. 2022. https:\/\/doi.org\/10.1016\/j.nrl.2021.11.006.","journal-title":"Neurologia"},{"issue":"1","key":"3883_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.17116\/neiro20238701164","volume":"87","author":"AV Trashin","year":"2023","unstructured":"Trashin AV, Shulev YA, Bogdanova EM. Quality of life in patients with hemifacial spasm after microvascular decompression and botulinum toxin therapy. Zh Vopr Neirokhir Im N N Burdenko. 2023;87(1):64\u20139. https:\/\/doi.org\/10.17116\/neiro20238701164. Otsenka kachestva zhizni patsientov s gemifatsial\u2019nym spazmom posle mikrovaskulyarnoi dekompressii i botulinoterapii.","journal-title":"Zh Vopr Neirokhir Im N N Burdenko"},{"issue":"3","key":"3883_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/toxins13030215","volume":"13","author":"S Kongsaengdao","year":"2021","unstructured":"Kongsaengdao S, Maneeton N, Maneeton B. The five-year prospective study of quality of life in hemifacial spasm treated with abo-botulinum toxin A. Toxins (Basel). 2021;13(3):215. https:\/\/doi.org\/10.3390\/toxins13030215.","journal-title":"Toxins (Basel)"},{"key":"3883_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuroscience.2014.12.070","volume":"289","author":"F Bao","year":"2015","unstructured":"Bao F, Wang Y, Liu J, et al. Structural changes in the CNS of patients with hemifacial spasm. Neuroscience. 2015;289:56\u201362. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.070.","journal-title":"Neuroscience"},{"issue":"2","key":"3883_CR58","doi-asserted-by":"publisher","first-page":"Np28","DOI":"10.1093\/asj\/sju027","volume":"35","author":"M Dobryansky","year":"2015","unstructured":"Dobryansky M, Korsh J, Shen AE, Aliano K. Botulinum toxin type A and B primary resistance. Aesthet Surg J. 2015;35(2):Np28-30. https:\/\/doi.org\/10.1093\/asj\/sju027.","journal-title":"Aesthet Surg J"},{"issue":"22 Suppl 6","key":"3883_CR59","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ajhp\/61.suppl_6.S5","volume":"61","author":"RG Wenzel","year":"2004","unstructured":"Wenzel RG. Pharmacology of botulinum neurotoxin serotype A. Am J Health Syst Pharm. 2004;61(22 Suppl 6):S5-10. https:\/\/doi.org\/10.1093\/ajhp\/61.suppl_6.S5.","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"3883_CR60","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00405-022-07796-8","volume":"280","author":"FW de Jongh","year":"2023","unstructured":"de Jongh FW, Schaeffers A, Kooreman ZE, et al. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2023;280(4):1581\u201392. https:\/\/doi.org\/10.1007\/s00405-022-07796-8.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"3883_CR61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00266-021-02483-1","volume":"46","author":"A Borba","year":"2022","unstructured":"Borba A, Matayoshi S, Rodrigues M. Avoiding complications on the upper face treatment with botulinum toxin: a practical guide. Aesthetic Plast Surg. 2022;46(1):385\u201394. https:\/\/doi.org\/10.1007\/s00266-021-02483-1.","journal-title":"Aesthetic Plast Surg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03883-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:31:48Z","timestamp":1730190708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03883-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03883-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors ensured our conform to the authorship policies and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}